Rongcan Biotech

BiotechnologySeries AShanghai, Chinarc-rna.com

Latest round

Series A

Last raised

Dec 2023

Total raised

$14M

Investors

5

About Rongcan Biotech

Established in 2020 and based in Wuhu, China, Rongcan Biotech operates as a nucleic acid drug developer, dedicated to the development and industrialization of gene drugs. The company's core technical members graduated from MIT and Harvard Medical School. It has established a joint laboratory of drug slow-release technology with Shanghai Jiao Tong University School of Pharmacy and has cooperated with WuXi AppTec Group and HuiGene Therapeutics. Rongcan Biotech has established a nucleic acid drug RTP R&D technology platform to research and develop mRNA and SiRNA drugs. The company's product pipelines cover drugs in respiratory, cardiovascular, and solid tumors, as well as mRNA vaccines for infectious diseases.

Who invested in Rongcan Biotech

5 investors across 2 rounds

See all investors in Rongcan Biotech

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Dec 6, 2023

    Amount

    $14M

    Investors

    Locked

  2. Angel

    Jun 24, 2020

    Amount

    Undisclosed

    Investors

    Locked

Questions about Rongcan Biotech

Who invested in Rongcan Biotech?

Rongcan Biotech has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Rongcan Biotech raised?

Rongcan Biotech has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Rongcan Biotech last raise money?

Rongcan Biotech's most recent round on record is a Series A, in Dec 2023.

What does Rongcan Biotech do?

Established in 2020 and based in Wuhu, China, Rongcan Biotech operates as a nucleic acid drug developer, dedicated to the development and industrialization of gene drugs.

Where is Rongcan Biotech headquartered?

Rongcan Biotech is headquartered in Shanghai, China.

Which VCs invest in companies like Rongcan Biotech?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Rongcan Biotech's stage. Their profiles are linked below.

Raising like Rongcan Biotech? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.